What smart money is saying about Indutrade AB
No fund has written a full thesis on Indutrade AB in our archive, but 3 fund letters report a position in it, most recently Spiltan Fonder Småbolagsfond in October 2026.
Get an email when a fund buys, sells or pitches it
Fund signal · last 12 months
3 lettersToo few moves on Indutrade AB yet for a clear signal
Moves described in fund letters in our archive. A sentence published word for word by several funds of one house in the same quarter counts once.
Position history
Between Q2 2026 and Q4 2026, 3 fund letters reported a position in Indutrade AB, with 1 buy (opened or added) and 2 sells (trimmed or exited).
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q4 2026 | 2 | 1 | 1 | 0 |
| Q2 2026 | 1 | 0 | 1 | 0 |
Bought and Sold count moves: the same sentence published by several funds of one house in a quarter counts once.
Fund activity · 3 positions · 3 moves
- TrimmedSpiltan Fonder SmåbolagsfondOctober 2026
“During the month we have slightly reduced in among others Addnode, Indutrade and Medicover, while we have continued to increase the holding in Tången Industrikapital.”
Indutrade AB - New positionSpiltan Aktiefond InvestmentbolagOctober 2026
“FUND MANAGER COMMENTARY October was characterised by sharp swings on the stock market, where several strong company reports acted as a counterweight in a market otherwise driven by global events. Fundamentally, uncertainty remains on the financial markets with the ongoing conflicts and wars, the recurring statements from the US administration and rising market interest rates. For companies, forward planning is made more difficult when the playing field is constantly changing. At the same time, we see that the companies' active work to adapt their operations to new conditions is having an effect. This creates opportunities for long-term investors. The fund was up 1.7% in October, which was better than the Stockholm Stock Exchange's rise of 0.8%. The fund's largest holding, Investor, was the main contributor, together with AstraZeneca, Hexagon and Kinnevik, while Lifco, Industrivärden and Addtech in particular weighed on the month's return. Looking at the entire portfolio, we can note that the fund's various holdings, even during a volatile month, generally balance the short-term market movements well. Year to date, the fund is up 16.4%, compared with the Stockholm Stock Exchange's rise of 11.6%. Also over longer time periods – three, five, ten years and since the fund's launch – the fund has developed clearly better than the market. Over time, we get to share in the value creation of the underlying companies, which operate in a range of different industries. To future-proof the fund, we have gradually complemented the portfolio with larger listed companies with investment company characteristics and conglomerate structure, which contributes to increased diversification. The largest additions are the industrial conglomerate Indutrade, the healthcare conglomerate Lifco, the technology conglomerate Hexagon and the pharmaceutical conglomerate AstraZeneca.”
Indutrade AB - June 2026
“We also exited three investments – Indutrade, HDFC Bank, and Wix – reallocating to names in which we saw a more attractive risk-reward profile.”
Indutrade AB
Read the letters behind these Indutrade AB positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves, and to Warren AI, which reads all of them for you.
View plans→